- In March 2025, Astorg, a prominent pan-European private equity firm, announced the launch of Nexpring Health—a global MedTech company focused on Assisted Reproductive Technology (ART). Nexpring Health was formed through Astorg’s strategic acquisitions of Hamilton Thorne, Cook Medical’s Reproductive Health business, and the anticipated acquisition of FUJIFILM Irvine Scientific’s Medical Media Business
- In October 2024, SpOvum unveiled its cutting‑edge, AI‑driven platform—SpOvum ARTPT—designed to transform patient engagement in Assisted Reproductive Technology. By harnessing natural language processing, ARTPT delivers instant, conversational support around the clock, ensuring patients receive guidance even when clinics are closed
